Morning Seminar March 26, 2009

Lancet Oncol. 2008 Sep;9(9):831-9.
Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.
Frassoni F, Gualandi F, Podestà M, Raiola AM, Ibatici A, Piaggio G, Sessarego M, Sessarego N, Gobbi M, Sacchi N, Labopin M, Bacigalupo A.

Morning Seminar March 24, 2009

Bone Marrow Transplant. 2009 Jan;43(2):149-53.
New classification of chronic GVHD: added clarity from the consensus diagnoses.
Arora M, Nagaraj S, Witte J, DeFor TE, MacMillan M, Burns LJ, Weisdorf DJ.

Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56.
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME.

Morning Seminar March 19, 2009

Blood. 2009 Feb 26;113(9):1906-8.
Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system.
Weinberg OK, Seetharam M, Ren L, Seo K, Ma L, Merker JD, Gotlib J, Zehnder JL, Arber DA.

Morning Seminar March 13, 2009

J Clin Oncol. 2009 Mar 10;27(8):1310-5.
Treatment of nonmetastatic cranial parameningeal rhabdomyosarcoma in children younger than 3 years old: results from international society of pediatric oncology studies MMT 89 and 95.
Defachelles AS, Rey A, Oberlin O, Spooner D, Stevens MC.

Morning Seminar March 5, 2009

Med Pediatr Oncol. 2003 May;40(5):276-87.
Treatment of Ewing sarcoma family of tumors: current status and outlook for the future.
Rodriguez-Galindo C, Spunt SL, Pappo AS.

J Clin Oncol. 2006 Aug 20;24(24):3997-4002.
Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
Oberlin O, Rey A, Desfachelles AS, Philip T, Plantaz D, Schmitt C, Plouvier E, Lejars O, Rubie H, Terrier P, Michon J; Société Française des Cancers de l'Enfant.

Ann Oncol. 2000 Nov;11(11):1451-62.
Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
Burdach S, van Kaick B, Laws HJ, Ahrens S, Haase R, Körholz D, Pape H, Dunst J, Kahn T, Willers R, Engel B, Dirksen U, Kramm C, Nürnberger W, Heyll A, Ladenstein R, Gadner H, Jürgens H, Go el U.

Morning Seminar March 3, 2009

J Clin Oncol. 2009 Jan 26. [Epub ahead of print]
Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma Without MYCN Gene Amplification.
De Bernardi B, Gerrard M, Boni L, Rubie H, Cañete A, Di Cataldo A, Castel V, Forjaz de Lacerda A, Ladenstein R, Ruud E, Brichard B, Couturier J, Ellershaw C, Munzer C, Bruzzi P, Michon J, Pearson AD.